The purpose of this cost analysis study conducted at six health facilites was to determine the costs of replacing the existing delivery method with oxytocin in Uniject® for the prevention of postpartum hemorrhage. This study complements a larger study on acceptability and feasibility, Pilot Introduction of Oxytocin in Uniject® During Active Management of the Third Stage of Labor (AMTSL) at the Institutional Level in Guatemala.

Corporate author(s): PATH

Publication date: March 2010

Available materials



Oxytocin in the Uniject® Prefilled Injection Device: Guatemala Pilot Introduction [Spanish]

300 KB PDF

Also known as: Oxitocina en el Dispositivo de Inyección Pre-llenado Uniject®: Piloto de Introducción en Guatemala

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Latin America

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA